Public-Private-Partnerships in Drug Research and Development

2025
ISBN: 978-3-031-75805-8
Verlag: Springer International Publishing

Buch, Englisch, Band 286, 196 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 519 g

Reihe: Handbook of Experimental Pharmacology

Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.

Zielgruppe

Research

Autoren/Hrsg.

Wieland, Heike A.

Michel, Martin C.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien

Inhaltsverzeichnis

Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update.- Project based Public private collaborations.- Collaborative Innovations in Childhood Cancer Therapies.- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development.- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model.- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe.- Innovation at the Interface between Academia and Industry The BioMed X Model.- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective.- The Legal Framework for PPP in Drug R&D.